Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Gross Profit (2020 - 2025)

Abeona Therapeutics has reported Gross Profit over the past 8 years, most recently at $4.4 million for Q4 2025.

  • Quarterly results put Gross Profit at $4.4 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $4.2 million (changed N/A YoY), and the annual figure for FY2025 was $4.3 million, changed.
  • Gross Profit for Q4 2025 was $4.4 million at Abeona Therapeutics, up from -$488000.0 in the prior quarter.
  • Over the last five years, Gross Profit for ABEO hit a ceiling of $4.4 million in Q4 2025 and a floor of -$488000.0 in Q3 2025.
  • Median Gross Profit over the past 3 years was $300000.0 (2025), compared with a mean of $957285.7.
  • Peak annual rise in Gross Profit hit 196.15% in 2023, while the deepest fall reached 196.15% in 2023.
  • Abeona Therapeutics' Gross Profit stood at -$32000.0 in 2022, then grew by 6.25% to -$30000.0 in 2023, then soared by 14686.67% to $4.4 million in 2025.
  • The last three reported values for Gross Profit were $4.4 million (Q4 2025), -$488000.0 (Q3 2025), and $300000.0 (Q2 2025) per Business Quant data.